Popular TV actor Hiten Tejwani reveals extreme work conditions in Indian television industry - 22-hour shifts for a month, earning just ₹1 lakh, and dangerous exhaustion that led to falling asleep at wheel.
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Indian steel giants face perfect storm as oversupply and cheap imports drive prices to 8-month lows. Discover how Tata Steel, JSW Steel, and SAIL are battling market pressures.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Meet the trailblazing female entrepreneurs who built healthcare empires from scratch and are reshaping medical innovation worldwide. Discover their inspiring journeys to billions.
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
In a major breakthrough, Narcotics Control Bureau uncovers sophisticated drug manufacturing unit in Madhya Pradesh's Ratlam district. Highly educated pharma graduates among those arrested in interstate narcotics operation.
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.
India's leading cement manufacturer Dalmia Bharat reports staggering 50% quarterly profit drop despite robust annual revenue growth. Discover how price weakness impacted Q2 results.
Seoul court confirms penalty against HYBE subsidiary for workplace harassment in high-profile case involving CEO Min Hee-jin. Details on the legal battle rocking K-entertainment industry.
Television industry unites in mourning as veteran actor Pankaj Dheer's prayer meet draws emotional tributes from son Nikitin Dheer, daughter-in-law Kratika Sengar, and TV celebrities.
Former Saints Row design director Chris Stockman argues GTA 6 should launch at $100 given its massive development costs and unprecedented scale. Discover why industry experts believe premium pricing might become standard for AAA titles.
As Oracle pushes deeper into artificial intelligence, industry experts demand clearer answers about the company's strategic direction and competitive positioning in the rapidly evolving AI landscape.
In a major development, popular drummer Manas Robin and co-singer Sanjay Dey, associated with musical icon Zubeen Garg, have been remanded to 14 days judicial custody in Haflong Jail following their arrest in a high-profile case.
In a surprising career move, Apple's AI division suffers another blow as senior executive Joaquin Quiñonero Candela joins Meta's AI team, raising eyebrows in tech circles about the ongoing talent war between tech giants.
JSW Steel announces strategic overhaul of US operations and merger of three domestic subsidiaries to boost efficiency and profitability. Key details revealed.
American semiconductor giant Micron Technology may soon close its operations in China, just two years after resolving a major ban dispute. This development signals escalating tech tensions between US and China.
Exclusive insider details reveal the massive paycheck that 'Love Today' director Pradeep Ranganathan earns per film, making him one of Tamil cinema's highest-paid filmmakers.